Monday, March 15, 2021
Reputation -- Again
AstraZeneca is having trouble getting its COVID vaccine to market. Its problem is causing supposed blood clots in recipients. Once a pharma company gets a bad reputation for its medicine, it is hard to come back. The onus is on the company to prove that its therapy is safe and effective. Ireland and the Netherlands aren't waiting for more data. They have suspended use of the vaccine as have several other countries. It now has a reputation for being second best and harmful. The pharma has a major task to rehabilitate the drug, and it may take months to do so.
Comments:
Post a Comment